Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
Annals of Neurology|May 11, 2000
Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?B P Bejjani, I Arnulf, S Demeret, et al.Annals of Neurology|April 1, 1994
Sequences of memory-guided saccades in Parkinson's diseaseA I Vermersch, S Rivaud, M Vidailhet, et al.Neurology|July 26, 2000
Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesisI Arnulf, A M Bonnet, P Damier, et al.Revue Neurologique|August 1, 1977
[Abnormal movements caused by L-DOPA in patients with Parkinson's disease: correlation with the plasma concentrations of DOPA and O-methyl-DOPA]F Lhermitte, Y Agid, C Feuerstein, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1989
Striatal dopamine D2 receptors in tardive dyskinesia: PET studyJ Blin, J C Baron, H Cambon, et al.Neurology|June 1, 1989
Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects testB Pillon, B Dubois, A M Bonnet, et al.Lancet (London, England)|September 29, 2004
Causal relation between alpha-synuclein gene duplication and familial Parkinson's diseaseP Ibáñez, A-M Bonnet, B Débarges, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's choreaA M Bonnet, G Tell, P J Schechter, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|June 1, 1979
Dopamine receptor stimulating agonists in the treatment of Parkinson's diseaseY Agid, G Barroche, A M Bonnet, et al.Annals of Neurology|April 1, 1994
Eye movements in parkinsonian syndromesM Vidailhet, S Rivaud, N Gouider-Khouja, et al.Pageof 7